Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
12.08
-0.53 (-4.20%)
At close: Apr 2, 2026, 4:00 PM EDT
12.65
+0.57 (4.72%)
After-hours: Apr 2, 2026, 5:11 PM EDT
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $19.6 million as of April 2, 2026. Its market cap has increased by 656.60% in one year.
Market Cap
19.60M
Enterprise Value
8.18M
1-Year Change
656.60%
Ranking
Category
Stock Price
$12.08
Market Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $19.60M, an increase of 201.44%. That is a compound annual growth rate of 117.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 20.46M | 51.16% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 22.21M |
| Skye Bioscience | 22.19M |
| Barinthus Biotherapeutics | 22.06M |
| Outlook Therapeutics | 21.97M |
| Marker Therapeutics | 21.84M |
| Lexaria Bioscience | 21.56M |
| Curis | 21.31M |
| NanoViricides | 20.61M |